A77 (P106) Diabetes Remission Clinical Trial (DiRECT): Does hepatic very low density lipoprotein (VLDL) production determine intrapancreatic fat in Type 2 diabetes?A AL‐MRABEH1, SV Zhyzhneuskaya1, C Peters1, AC Barnes2, B Aribisala3, KG Hollingsworth1, H Pilkington4, MEJ Lean5 and R Taylor1Magnetic Resonance Centre, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK, 2Human Nutrition Research Centre, Institute of Health and Society, Newcastle University, Newcastle upon Tyne, UK, 3Computer Science Department, Faculty of Science, Lagos State University, Lagos, Nigeria, 4Clinical Ageing Research Unit, Campus for Ageing and Vitality, Newcastle University, Newcastle upon Tyne, UK, 5School of Medicine, Dentistry and Nursing, Royal Infirmary, University of Glasgow, Glasgow, UKAim: VLDL‐triglyceride (VLDL‐TG) supplies fat to all organs. It was hypothesised that following weight loss, the fall in pancreatic fat and improvement in insulin secretion are driven by the decrease in hepatic VLDL production.Methods: The Tyneside cohort of DiRECT (n = 90, age 52.8 ± 0.8 years, body mass index 34.7 ± 0.5 kg/m2, HbA1c 58.8 ± 1.2 mmol/mol) underwent detailed metabolic tests at baseline and after weight loss (825 to 853 kcal/day). Intra‐organ fat was quantified using 3‐point Dixon magnetic resonance imaging, and hepatic very low density lipoprotein 1 (VLDL1‐TG) production was measured using a competitive blocking non‐isotopic method. Insulin secretion was measured by
Diabetic Medicine – Wiley
Published: Jan 1, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera